The effectiveness of the PPSV varies depending on the population group and specific health conditions. In general, the vaccine has been shown to be 60-70% effective in preventing invasive pneumococcal disease. Its efficacy is lower in those with significant underlying health conditions, but it still provides substantial protection.
